A Study of LY3045697 After Multiple Oral Dosing in Healthy Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of this study is to investigate the safety and tolerability of LY3045697 after multiple doses and to determine how long LY3045697 remains in the body. Each participant is expected to complete 3 dosing periods. At least 7 days will pass between dosing periods.
Epistemonikos ID: 33c69b24a8876623814a0392ab343c33183bb026
First added on: May 11, 2024